Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer
- 24/07/2024, 09:03
-
ansa.it
0
Scopri altro
- 24/09/2024, 09:03
-
ansa.it
-
0
- 24/09/2024, 09:03
-
ansa.it
-
0
- 24/09/2024, 09:00
-
open.online
-
0
- 24/09/2024, 08:49
-
repubblica.it
-
0
- 24/09/2024, 08:32
-
ansa.it
-
0
- 24/09/2024, 08:29
-
ansa.it
-
0
- 24/09/2024, 08:18
-
ansa.it
-
0
Nessun commento